Medical Devices: Current scenario and need of the hour

Medical Devices: Current scenario and need of the hour

137
Bp Apparatus, Medical Devices
Picture: Pixabay

Last Updated on December 18, 2021 by The Health Master

Medical Devices: Current scenario and need of the hour

Even as experts continue to debate and speculate over the eventuality of a third C-19 wave, its intensity, and probable new symptoms and new strains, the need to attain self-reliance will remain a watchword of India’s health governance.

And fostering and development of an indigenous world-class medical device industry will be an integral part of that self-reliance drive.

What is the current status of the industry and what can be done more in terms of policy and other ways to steer it into a direction and path of self-reliance?

The prevailing medical devices landscape

As the fourth largest market for medical devices in Asia, as of 2021, India is an $ 11 billion market. With a projected CAGR of 37 percent in the coming future, the industry is expected to reach a market size of $ 50 billion by 2025.

[1] Currently, there are nearly 750-800 domestic manufacturers in India, with an average investment of $ 2.3-2.7 million and an average turnover of $ 6.2-6.9 million.

[2] At the same time, there are over 6,000 startups.

Some of the key states that serve as medical device manufacturing hubs include Gujarat, Maharashtra, Karnataka, Haryana, Andhra Pradesh, Telangana, and Tamil Nadu. Yet, India imports nearly 80 percent of its medical devices.

For its part, the government has ensured that a favorable policy climate exists for investment from outside. With 100 per cent FDI being allowed under the automatic route for both greenfield and brownfield establishments, until June 2021, the country has notched up investments worth $ 2.23 billion.

Notably, between financial year 2019 and 2020, the investment had almost doubled Y-o-Y to over $ 301 million.

[3] At the same time, the US, Germany, China, Brazil and Iran have been key importers of Indian medical devices.

Where the industry falls short: domestic manufacturers catching up, yet patchy

Notwithstanding the impressive numbers, and besides the fact that the country is dependent on nearly 80 percent of its needs on imports, its domestic manufacturers are mainly focused on relatively low-end products such as consumables, surgical, cardiac stents and implants, and general medical devices.

The high-end technology products are mainly dominated by foreign players either through investments or the export route. In fact, electronics and equipment constitute a sizeable 56 per cent of the country’s medical devices imports.

However, C-19 has definitely given an impetus to a flourishing diagnostics and imaging sector with over 2500 labs now conducting advanced molecular tests such as RT-PCR tests.

In addition, domestic manufacturers are also coming up with upgraded implants and prosthetics technologies, technologically-advanced life support systems such as ventilators, automated external defibrillators (AEDs) and oxygen concentrators besides an array of modern automated and precision surgical tools and systems for different conditions. Yet, these recent developments are few and far between on a national level.

Regulations afoot to push the industry for quality and competitiveness       

For its part, the government has in recent years attempted to streamline the regulatory framework for the industry with a series of rules and guidelines. The Medical Devices Rules 2017 prescribed a four-fold risk-based classification system covering all medical devices and equipment.

Then the Medical Devices (Amendment) Rules 2020 has provided for a separate regulatory framework for medical devices divorced from drugs while also mandating companies to compulsorily register on a government-designated portal and acquire license for operations.

Stipulating ISO 13485 as a pre-condition for registration would ensure that domestic manufacturers can compete in the world market and would be treated on equal terms with leading global companies.

Governments’ initiatives on medical device parks and PLIs  

Along with regulatory initiatives, the central government and states have also attempted to give an impetus to domestic manufacturing by way of setting up clusters and medical device parks within the country as well as through production linked incentives (PLIs).

Already, the state governments of Himachal Pradesh, Tamil Nadu, Madhya Pradesh, and Uttar Pradesh have given “in-principle” approval to develop medical device parks.

So, while Gautam Budh Nagar, Noida, is expected to have Northern India’s first medical tools and system manufacturing park by 2022, the Punjab government has also announced a medical device park at Rajpura.

[4] Furthermore, the government has also announced a PLI scheme for making medical devices in four segments that includes devices for cancer care, radiology and imaging, anaesthetics and cardio-respiratory devices, and all implants, including implantable electronic devices.

The scheme is to extend incentives at the rate of 5 per cent of incremental sales to eligible applicants.

What more can be done

So, while these have been commendable steps, there is a lot more that needs to be done to enable the emergence and indeed flourishing of an international quality and globally competitive domestic medical device industry.

  • Motivate buyers (hospitals) to buy genuine Make in India medtech devices. Offer rebate on purchase and Provisions for higher depreciation Indian medical device purchase.
  • Additional incentive for R&D expenses to be invested to the current scheme, requires fulfillment of complex procedure of defining the manufacturing industry. Bank can be made responsible to recognise award and the status of R&D house. Using this can endorse the existence of R&D activities. Local industry association can endorse the existence
  • Educational Institution can get associated with medical device industries by adding subjects on Medical Devices daily studies. Full time involvement of students with industrial activities in R&D. The current allocation of time is very much insufficient (current allocation by most of the University is One semester, half/one day per week)
  • Support from local education institutions for educating industry and their representatives in to exposure to new technologies, process of device certification, applicability of product standards, interpretation of product standards, implementation of requirements of product standards, guidelines for testing.
  • BIS and OCI to allow easy access to all the required standards
  • ERTL, E2DC, DRDO, provide guidance in finding applicable standards for particular medical device as and when requested by industry.
  • Simple process of filing patents, registration of designs, copy rights (… within… Indian territory)
  • Concessional Inclusion from labor laws, factory act, employment law for R&D employees and man power. So that industry can grow at faster pace.
  • Allow medical device industry to execute legal contract for minimum service duration.
  • Faster and shorter reverts for legal actions, structural roles and punishments for Protection of IP rights and theft of intellectual property.
  • Product imported under CKD or knockdown condition that is reassembled and re-label in India should be discouraged. So, with these steps, the Indian medical device sector can not only truly become self-reliant but also go a long way in contributing to quality healthcare for Indians in India!

References:

[1] https://www.investindia.gov.in/sector/medical-devices

[2] https://www.investindia.gov.in/sector/medical-devices

[3] https://www.ibef.org/industry/medical-devices.aspx

[4] https://www.ibef.org/industry/medical-devices.aspx

By Ashok Patel, CEO and Founder, Max Ventilator

Licensing procedure for Medical devices

Latest Notifications: Medical Devices

Classifications of Medical Devices under the provisions of MDR 2017

FAQs on Medical Devices Rules, 2017   

FAQs – on Blood Pressure Monitoring Devices

Govt notifies NIB, Noida as CDL to test Covid-19 vaccines

USFDA issues Form 483 to Alembic Pharma Gujarat plant

Pharma Manufacturing & Packaging Congress to be held in June 2022

USFDA approves generic drug for Blood Pressure

FDA Haryana and police unearthed a unit manufacturing spurious cosmetics

In-service Pharmacists authorised to dispense drugs for these 8 common ailments

Recruitment of 87 Drug Inspectors put on hold in Maharashtra

NDPS: 9 arrested for selling drugs

Procedure for registration of Medical Devices: CDSCO

Latest Notifications regarding Pharmaceuticals

For informative videos by The Health Master, click on the below YouTube icon:

YouTube Icon
Telegram
WhatsApp
Facebook
LinkedIn
YouTube Icon
Google-news

Enter your email address:

Delivered by FeedBurner